With AI and a wristband, the company continues its rapid global expansion of a proactive health technology, backed by prominent investors.
The wearable tech landscape just experienced a seismic shift. WHOOP, the Boston-based human performance company, has officially crossed into “decacorn” territory, announcing a massive $575 million Series G funding round at a valuation of $10.1 billion.
Some of the most prominent names in the worlds of elite sport, sovereign wealth, and institutional healthcare have provided a global endorsement.
“Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan,” said Will Ahmed, Founder and CEO of WHOOP. “We are building the personal health platform that people use to improve their health and livelihood.”
A “Who’s Who” of Global Investors
The round was led by Collaborative Fund, but the list of participants comprises the world’s most influential leaders.
Elite Athletes & Icons: The “WHOOP effect” is perhaps most visible in its athlete-investors. Cristiano Ronaldo, LeBron James, and Rory McIlroy. These athletes are defined by their longevity and passion for data. Joining them are stars like Virgil van Dijk, Niall Horan, and Michael Jordan’s brand partner, 2PointZero Group.
“WHOOP has become one of the most important tools I use to support my long-term health,” said Cristiano Ronaldo. “No other company has created a health platform this powerful that people are proud to wear.”
Institutional & Sovereign Power: The funding also saw heavy participation from global heavyweights, including:
- Qatar Investment Authority (QIA) and Mubadala Investment Company, signaling massive expansion plans for the GCC region.
- Abbott and Mayo Clinic, highlighting WHOOP’s transition from a fitness tracker to a serious medical and diagnostic tool.
From Fitness Tracker to Health Predictor
The $10.1 billion valuation comes on the heels of an explosive 2025, where WHOOP saw 103% year-over-year growth and reached a $1.1 billion revenue run rate. Global membership now surpasses 2.5 million.
But why is the world’s elite so bullish on a screenless wristband? The answer lies in the data.
WHOOP now manages over 24 billion hours of physiological data, using AI to shift healthcare from reactive (treating you when you’re sick) to proactive (preventing illness before it starts).
With new features like an FDA-cleared ECG, blood pressure insights, and “Advanced Labs” for blood biomarker analysis, WHOOP looks to be the “dashboard for the human body.”
Its powerful 24/7 wearable provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity.
What’s Next: Global Domination
WHOOP founder and CEO Will Ahmed has clear sight on the future. The company plans to:
- Hire 600+ new roles globally this year.
- Expand aggressively into markets across Europe, Asia, Latin America, and the Middle East.
- Scale R&D to further integrate AI-driven health predictions into daily life.
As chronic diseases rise globally, WHOOP is betting that the future of health isn’t in a doctor’s office, but on your wrist—backed by the greatest athletes and the deepest pockets in the world.
Looking to optimize your own performance? WHOOP currently offers a one-month free trial for new members at whoop.com.With AI and a wristband, the company continues its rapid global expansion of a proactive health technology with the support of prominent investors.
